ALS Masitinib Allergy Olopatadine / mometasone Antithrombotic medications Andexanet alfa Betrixaban Ciraparantag Dabigatran etexilaat Rivaroxaban Asthma Benralizumab Dupilumab Tiotropium Tralokinumab Bacterial infections Amoxicilline / omeprazol / rifabutin Cadazolid Eravacycline Iclaprim Imipenem / Relebactam Liposomaal amikacine Meropenem / vaborbactam Nemonoxacin Omadacycline Ozenoxacine Bladder cancer Atezolizumab Durvalumab Durvalumab / Tremelimumab Ramucirumab Bowel diseases Alicaforsen Pouchitis Ulcerative colitis Darvadstrocel Etrolizumab Ulcerative colitis Ziekte van Crohn Masitinib Remestemcel-L Rifaximin Tenapanor Tofacitinib Ustekinumab Brain cancer Brain cancer vaccine Depatuxizumab mafodotin Breast cancer Abemaciclib Atezolizumab Neratinib Olaparib Pembrolizumab Pertuzumab Ribociclib Breast cancer, advanced metastatic, HR+ and HER2-, in combination with fulvestrant, postmenopausal women and men, 1L en 2L. Breast cancer, advanced metastatic, HR+ and HER2-, in combination with tamoxifen and goserelin or a non-steroidal aromatase inhibitor (NSAI) and goserelin, premenopausal women. Talazoparib Veliparib COPD Benralizumab Fluticasone furoate / umeclidinium (bromide) / vilanterol (trifenatate) Formoterol / glycopyronium / budesonide Glycopyrrolate / formoterol Mepolizumab Revefenacin Cardiovascular diseases Avacopan Colon cancer Atezolizumab Nivolumab Cystic fibrosis Ivacaftor Tezacaftor / ivacaftor Dementia Leuco-methylthioninium Alzheimer’s disease, mild-to-moderate. Dementia, behavioural variant frontotemporal. Diabetes Dapagliflozine Empagliflozine Ertugliflozin Ertugliflozin / metformin Ertugliflozin / sitagliptin Exenatide Diabetes type 2 Diabetes type 2 Glibenclamide Semaglutide Sotagliflozin Epilepsy Vigabatrin Eye disorders Brolucizumab Cenegermin Ciclosporin Keratoconjunctivitis sicca (or dry eye disease), moderate-to-severe and specifically in patients with atopic keratoconjunctivitis. Treatment of severe vernal keratoconjunctivitis in children from 4 years of age and adolescents. Eculizumab KPI-121 Dry eye disease. Ocular pain and inflammation. Om te gebruiken na oogchirurgie. Latanoprostene bunod Lifitegrast Mercaptamine RGN-259 Voretigene neparvovec Graft versus Host Ibrutinib Itacitinib Head and neck cancer Afatinib Brilacidin Durvalumab Squamous cell carcinoma of the head and neck, 1L PDL 1. Squamous cell carcinoma of the head and neck, 2L Durvalumab / Tremelimumab Head and neck (or upper airways tract) cancers; squamous cell carcinoma of head or neck (SCCHN), 2L Durvalumab monotherapy in PDL1-positive tumours or in combination with Tremelimumab for PDL1-negative tumours. Squamous cell carcinoma of the head and neck, 1L PDL 1 Pembrolizumab Headache Eptinezumab Erenumab Fremanezumab Galcanezumab Prophylactic treatment of migraine headache. Clusterhoofdpijn Lasmiditan Hemostasis promoting medication Damoctocog alfa pegol Emicizumab Hemlibra is geïndiceerd voor de routineprofylaxe van bloedingen bij patiënten met hemofilie A met remmers tegen factor VIII. Hemlibra kan bij alle leeftijdsgroepen worden gebruikt. Hemlibra is geïndiceerd voor de routinematige profylaxe van bloedingen bij patiënten met hemofilie A zonder remmers tegen factor VIII. Eptacog beta (activated) Rurioctocog alfa pegol Vonicog alfa Hormonal disorders Abaloparatide Elagolix Enclomifene Glucagon Macimorelin Osilodrostat Prasterone Recombinant parathyroid hormone Tenapanor Kidney cancer Atezolizumab Avelumab Ipilimumab Rocapuldencel-T Sunitinib Leukemia Blinatumomab Adults with minimal residual disease (MRD) positive B-cell precursor acute lymphoblastic leukaemia (ALL). Relapsed / Refractory Ph+ Adult Acute Lymphoblastic Leukemia (ALL). Relapsed / Refractory precursor-B Acute Lymphoblastic Leukemia (ALL) in children. Bosutinib Cytarabine / daunorubicin (liposomaal) Dasatinib Indicated for the treatment of paediatric patients with newly diagnosed Ph+ CML in chronic phase (Ph+ CML-CP) or Ph+ CML-CP resistant or intolerant to prior therapy including imatinib. Pediatric ALL Duvelisib Enasidenib Eryaspase (Asparaginase) Gemtuzumab ozogamicin Gilteritinib Ibrutinib 1L Chronic Lymphatic Leukemia young and fit patients Chronische Lymfatische Leukemie 1L, non-fit icm obinutuzumab Idelalisib Imetelstat Inotuzumab ozogamicin Sapacitabine Tamibarotene Tisagenlecleucel-T Venetoclax / cytarabine Venetoclax in combinatie met rituximab Lipid-lowering medications Alirocumab Evolocumab Volanesorsen (sodium) Liver cancer Cabozantinib Nivolumab Ramucirumab Liver diseases Obeticholic acid Lung cancer Atezolizumab Tecentriq is als monotherapie geïndiceerd voor de behandeling van volwassen patiënten met lokaal gevorderde of gemetastaseerde niet-kleincellige longkanker (NSCLC) na eerdere behandeling met chemotherapie. Patiënten met EGFR-activerende mutaties of ALK-positieve mutaties moeten ook doelgerichte behandeling hebben ontvangen voor ze Tecentriq krijgen. First line treatment of advanced non-squamous non-small cell lung cancer (NSCLC). Combination of Tecentriq, Avastin and chemotherapy. For the 1L treatment of patients with metastatic, squamous NSCLC in combination with chemotherapy Avelumab Brigatinib Durvalumab Non-small cell lung cancer (NSCLC) stage III, unresectable. Non-small cell lung cancer (NSCLC), 1L monotherapy Durvalumab / Tremelimumab Lorlatinib Lurbinectedin Osimertinib Rociletinib Rovalpituzumab tesirine Veliparib Lymphoma Axicabtagene ciloleucel Brentuximab vedotin Ibrutinib Follicular lymphoma (FL), relapsed / refractory. Mantle cell lymphoma (MCL), 1L. Marginal zone lymphoma (MZL), relapsed / refractory. Non-germinal center B-cell-like (non-GCB) diffuse large B-cell lymphoma (DLBCL), 1L. Waldenstrom's macroglobulinemia (WM) in combinatie met Rituximab Lenalidomide / Rituximab Mogamulizumab Tisagenlecleucel-T Mesothelioma Nintedanib Nivolumab Metabolic diseases Asfotase alfa Burosumab Cerliponase alfa Chenodeoxycholzuur Cyclodextrine (Hydroxypropyl betadex) Ibiglustat Idursulfase-IT Kaliumcitraat / kaliumwaterstofcarbonaat Metreleptin Neod001 Patiromer Pegvaliase Sebelipase alfa Sodium benzoate Sodium zirconium cyclosilicate Velmanase alfa Vestronidase alfa Multiple Myeloma Carfilzomib Daratumumab Multipel myeloom frontline behandeling in combinatie met Rd, non fit voor ASCT. Multipel myeloom frontline behandeling in combinatie met VMP non fit voor ASCT. Multipel myeloom frontline behandeling voor ASCT in combinatie met VTD. Denosumab Lenalidomide / bortezomib / dexamethason Plitidepsin Pomalidomide / bortezomib / dexamethason Multiple sclerosis ALKS8700 Cladribine Masitinib Ocrelizumab Volwassen patiënten met actieve relapsing multiple sclerose (RMS) die is gedefinieerd door klinische of beeldvormende kenmerken. Volwassen patiënten met vroege primair progressieve multiple sclerose (PPMS) gebaseerd op de ziekteduur, mate van invaliditeit en beeldvormende kenmerken die typerend zijn voor ontstekingsactiviteit. Ozanimod Siponimod Muscular diseases Adeno-associated viral vector serotype 9 containing the human SMN gene (AVXS-101) Botulinum A toxin Lower limb spasticity (LLS), in adults post stroke or traumatic brain injury (TBI). Lower limb spasticity (LLS), post stroke. Eteplirsen Ibudilast Idebenone Mexiletine HCl Nusinersen Valbenazine Neuroendocrine cancer Lutetium (177Lu) oxodotreotide Selumetinib Telotristat etiprate Other chronic immune diseases Budesonide Forigerimod (Rigerimod) Lanadelumab Lesinurad / allopurinol Tocilizumab Triamcinolone Other hematology Donor-derived T-lymphocyte enriched leukocyte preparation depleted ex vivo of host-alloreactive T cells. Fedratinib Myelofibrosis Polycythemia vera Lusutrombopag Pacritinib Romiplostim Ropeginterferon alfa-2b Treosulfan Other infectious diseases Isavuconazole Other lung Alpha-1 antitrypsin Mepolizumab Nintedanib Pirfenidone Rituximab Sirolimus Other medication for cardiovascular diseases Allogenic immunomodulatory progenitor cells Canakinumab Ticagrelor Valsartan / sacubitril Other metabolism and Endocrinology Romosozumab Other neurological disorders Botulinum A toxin CM-AT / CM-4612 Esketamine Inotersen Patisiran Other non-oncological hematological medications Avatrombopag Caplacizumab Ferumoxytol Rivipansel Sodium Other oncology Entolimod Larotrectinib Pembrolizumab Other viral infections Bictegravir / emtricitabine / tenofovir alafenamide fumaraat CMV DNA vaccin (ASP0113) Dolutegravir / rilpivirine Doravirine Doravirine / lamivudine / tenofovir disoproxil (fumarate) Fostemsavir Letermovir Peramivir Recombinant zoster vaccin Sofosbuvir / velpatasvir / voxilaprevir Zanamivir Ovarian cancer Avelumab Niraparib (tosylate monohydrate) Olaparib Lynparza is geïndiceerd als monotherapie voor de onderhoudsbehandeling van volwassen patiënten met platinasensitief recidief hooggradig epitheliaal ovarium, tuba- of primair peritoneaal carcinoom die een respons (volledige of partiële) vertonen op platinabevattende chemotherapie. BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. Olaparib / Cediranib Rucaparib Veliparib Pain Oxycodon ER Pancreatic cancer Olaparib Parkinson's Pimavanserin Prostate cancer Apalutamide Chemo-naieve gemetastaseerde castratie resistente prostaat carcinoom, in combinatie met Abiraterone. Gemetastaseerde hormoon-gevoelige, hoog-volume prostaat carcinoom. Niet-gemetastaseerde castratie resistente prostaat carcinoom. Darolutamide Enzalutamide Adult men with newly diagnosed high risk metastatic hormone sensitive prostate cancer (mHSPC) in combination with androgen depreviation therapy. Niet gemetastaseerde castratieresistente prostaatkanker (M0CRPC). Olaparib Padeliporfin Psychiatry Brexpiprazole Cariprazine Schizofrenie bij volwassenen. Bipolaire depressie Esketamine Lurasidone Rheumatism Infliximab SC Ixekizumab Alleen of in combinatie met methotrexaat geïndiceerd voor de behandeling van actieve artritis psoriatica bij volwassen patiënten die één of meer therapieën met disease-modifying antirheumatic drugs (DMARDs) niet verdroegen of daar ontoereikend op reageerden. Axiale Spondyloartritis Tofacitinib Upadacitinib Skin cancer Binimetinib Cemiplimab Dabrafenib / Trametinib Encorafenib LN-144 (TIL) Nivolumab Pembrolizumab Skin diseases Bimekizumab Certolizumab pegol Dupilumab Dupixent is geïndiceerd voor de behandeling van matig-ernstige tot ernstige atopische dermatitis bij volwassenen die in aanmerking komen voor een systemische behandeling. Atopische dermatitis bij kinderen Guselkumab Nemolizumab Risankizumab Tildrakizumab Tralokinumab Ustekinumab Sleep disorders Melatonin Pitolisant Tasimelteon Stomach cancer Atezolizumab Masitinib Nivolumab Pembrolizumab